JoVE Logo
Faculty Resource Center

Sign In

Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids (Video) | JoVE

DOI :

10.3791/63039-v

8:52 min

November 22nd, 2021

November 22nd, 2021

3,307 Views

1Department of Medicine, University of California, San Francisco, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 3Department of Cellular and Molecular Pharmacology, University of California, San Francisco

This protocol describes a standardized evaluation of drug sensitivities to targeted signaling inhibitors in NSCLC patient-derived organoid models.

Tags

Organoids

-- Views

Related Videos

article

Spatial Profiling of Protein and RNA Expression in Tissue: An Approach to Fine-Tune Virtual Microdissection (Video) | JoVE

article

Exploring Mitochondrial Energy Metabolism of Single 3D Microtissue Spheroids Using Extracellular Flux Analysis (Video) | JoVE

article

Establishing 3-Dimensional Spheroids from Patient-Derived Tumor Samples and Evaluating their Sensitivity to Drugs (Video) | JoVE

article

Generation and Culturing of High-Grade Serous Ovarian Cancer Patient-Derived Organoids (Video) | JoVE

article

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model (Video) | JoVE

article

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer (Video) | JoVE

article

Establishment and Culture of Patient-Derived Breast Organoids (Video) | JoVE

article

Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays (Video) | JoVE

article

Optimization of Performance Parameters of the TAGGG Telomere Length Assay (Video) | JoVE

article

Establishment of Zebrafish Patient-Derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing (Video) | JoVE

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved